Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with Oxaliplatin and Irinotecan for Peritoneal Carcinomatosis
NCT00180960Phase 2Terminated
- Sponsor
- Gustave Roussy
- Start
- Jun 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, irinotecan in peritoneal carcinomatosis (PC), sponsored by Gustave Roussy. Started Jun 2003; status: terminated.
02
Drugs
oxaliplatinirinotecan
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT00180960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180960.